ARCHIVES

Broder Appointment Official; Will Keep Retroviral Laboratory, Will Not Serve as NCI Clinical Director

This article is from The Cancer Letter archive.

Vol. 15 No. 01 | January 6, 1989

Download PDF Visit The Full Archive

Related Articles

The Cancer Letter Obtains “Confidential” Documents From Duke IRB Investigation

May 14, 2010

Phase III Afatinib Trial Met Primary Endpoint In Stage IIIb or IV Cancer with EGFR Mutation

June 29, 2012

Genetic Risk Factor Implicated In Prostate Cancer In Blacks

August 25, 2006

Ten Is The New 12: Medicare Lowers Hemoglobin Targets For ESA Use.

August 3, 2007

Increased Breast Density Can Lead to Higher Risk

August 26, 2011

Clinical Oncology Grant Funding: The History Of a Controversy

July 23, 1993